For the Inventor, By the Inventor

Enter assignee name

Dublin, OH, United States of America

Neoprobe Corporation

Calculating rank

USPTO Granted Patents = 36

CIPO Patents = 8

Trademarks = 3

Forward Citations = 1,473

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Marlin O Thurston (14 out of 26 patents)

Daniel A Kramer (10 out of 13 patents)

Karl W Olson (7 out of 14 patents)

4. William Godwin Atterbury (6 out of 57 patents)

5. Donald J Hackman (5 out of 36 patents)

6. James E Dvorsky (5 out of 35 patents)

7. Dennis Joseph Denen (4 out of 45 patents)

8. James S Couch (4 out of 10 patents)

9. Maaike Louise Evers (4 out of 80 patents)

10. Beth A Gahagan (4 out of 6 patents)

11. Beth A Kizer (4 out of 4 patents)

12. Chad Edward Bouton (3 out of 58 patents)

13. John D Call (3 out of 4 patents)

14. Raymond C Ramsey (3 out of 4 patents)

15. Edward W Martin (1 out of 12 patents)

Core Competencies:

Radiation Emission

Surgical Probe

Photon Emission

Radiation Detection

Tumor Cells

Detector Unit

Laparoscopic Instrument

Neoplasms

Gamma Radiation

Sensitivity Modulation

Crystal Array

Tracking System

36 patents: Sort by Forward Citations

1. 6272373 - Scanning system and method for locating sources of radiation emission (2001-08-07),

2. 6259095 - System and apparatus for detecting and locating sources of radiation (2001-07-10),

3. 6222193 - Radiation responsive surgical probe apparatus (2001-04-24),

4. 6218669 - Surgical probe apparatus (2001-04-17),

5. 6204505 - Surgical probe apparatus and system (2001-03-20),

6. 6202198 - Programmable integrated analog input/output circuit with distributed matching memory array (2001-03-13),

7. 6191422 - Radiation probe with compound semiconductor crystal performing in a trapping-dependent operational mode (2001-02-20),

8. 6144876 - Scanning a radiation source with a count rate output derived with a (2000-11-07),

9. 6093381 - Modulation of the sensitivity of tumor cells to chemotherapeutics (2000-07-25),

10. D424453 - Detector unit for radiation detecting probe (2000-05-09),

11. D423377 - Radiation detecting probe (2000-04-25),

12. 5987350 - Surgical probe apparatus and system (1999-11-16),

13. D413533 - Console for controlling a radiation probe (1999-09-07),

14. D413532 - Radiation detecting probe (1999-09-07),

15. 5928150 - System for locating and detecting a source of photon emissions (1999-07-27),

Company Overview

Neoprobe Corporation is a medical device company based in Dublin, Ohio, specializing in innovative solutions for the detection and treatment of cancer. The company focuses on developing advanced imaging technologies and radiopharmaceuticals that enhance surgical precision and improve patient outcomes. With a commitment to advancing healthcare, Neoprobe's research and development efforts are centered on creating tools that assist in the accurate localization of tumors and the effective management of cancer treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

36 Patents

#6 in Dublin, OH

#409 in Ohio

#9,527 in US

#18,762 in the World

Dublin, OH, United States of America

Neoprobe Corporation

Forward Citations = 1,473

29 inventors:

Marlin O Thurston (14 out of 26 patents)

Daniel A Kramer (10 out of 13 patents)

Karl W Olson (7 out of 14 patents)

4. William Godwin Atterbury (6 out of 57 patents)

5. Donald J Hackman (5 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neoprobe Corporation. Retrieved from https://idiyas.com/company/neoprobe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…